Xencor reported $60.94M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Abbvie ABBV:US $ 32521M 2673M
Alnylam Pharmaceuticals ALNY:US $ 605.96M 89.75M
Amgen AMGN:US $ 12886M 702M
Arrowhead Research ARWR:US $ 138.86M 1.82M
AstraZeneca AZN:LN 22740M 146M
Biogen BIIB:US $ 3946.6M 351.6M
Bristol Myers Squibb BMY:US $ 22821M 953M
Cytokinetics CYTK:US $ 66.85M 5.01M
Epizyme EPZM:US $ 38.97M 6.23M
GlaxoSmithKline GSK:LN 24278M 608M
Johnson & Johnson JNJ:US $ 43390M 1836M
Karyopharm Therapeutics KPTI:US $ 66.34M 7.38M
Macrogenics MGNX:US $ 67.1M 7.48M
Merk MRK:US $ 22316M 1556M
Novartis NOVN:VX SF 29807M 401M
Pfizer PFE:US $ 39268M 3403M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M
Seattle Genetics SGEN:US $ 531.29M 37.56M
Xencor XNCR:US $ 60.94M 9.8M